Prostatis Group’s Vanguard FTSE Developed Markets ETF VEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,315
Closed -$267K 159
2024
Q1
$267K Buy
+5,315
New +$257K 0.1% 121
2023
Q3
Sell
-78,224
Closed -$83.2K 237
2023
Q2
$83.2K Buy
+78,224
New +$3.6M 0.04% 145

Other funds holding VEA

Prostatis Group's VEA Position: Q2 2024 in Review

Prostatis Group sold out of Vanguard FTSE Developed Markets ETF (VEA) in Q2 2024, closing a stake of 5,315 shares — an estimated $267K sold.

Prostatis Group first reported a position in VEA in Q2 2023 and held it in 2 quarters. The position peaked at $267K in Q1 2024. 2,157 funds tracked by Wall St. Rank hold VEA as of Q2 2024.

  • Prostatis Group reported no remaining Vanguard FTSE Developed Markets ETF position as of Q2 2024 after selling out during the quarter.
  • Prostatis Group sold 5,315 Vanguard FTSE Developed Markets ETF shares in Q2 2024, an estimated $267K.
  • Prostatis Group first reported a position in Vanguard FTSE Developed Markets ETF in Q2 2023 and held it in 2 quarters.
  • Prostatis Group's Vanguard FTSE Developed Markets ETF position peaked at $267K in Q1 2024.
  • 2,157 funds tracked by Wall St. Rank held Vanguard FTSE Developed Markets ETF as of Q2 2024.

Based on Prostatis Group's 13F filing for Q2 2024, filed 21 Mar 2025.